Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Argentinian (MERVAL) Pharma Industry Analysis

UpdatedJun 30, 2026
DataAggregated Company Financials
Companies1
  • 7D-3.4%
  • 3M-5.4%
  • 1Y9.0%
  • YTDn/a

In the last week, the Pharma industry is flat overall, with Laboratorios RichmondC.I.F standing out by going down 3.4%. The past year has been better, since the industry has gained 15% in that time.

Industry Valuation and Performance

Has the Argentinian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 30 Jun 2026AR$129.2bAR$119.6bAR$16.1b7.9x8x1.1x
Thu, 28 May 2026AR$131.2bAR$119.6bAR$16.1b8.2x8.2x1.1x
Sat, 25 Apr 2026AR$126.8bAR$126.7bAR$2.4b54.2x52.7x1x
Mon, 23 Mar 2026AR$140.7bAR$130.8b-AR$1,946,644,487.0055.8x-72.3x1.1x
Wed, 18 Feb 2026AR$165.4bAR$107.5b-AR$10,024,883,532.00n/a-16.5x1.5x
Fri, 16 Jan 2026AR$160.9bAR$108.5b-AR$8,970,776,885.00n/a-17.9x1.5x
Sun, 14 Dec 2025AR$182.3bAR$108.5b-AR$8,970,776,885.00n/a-20.3x1.7x
Tue, 11 Nov 2025AR$133.0bAR$108.5b-AR$8,970,776,885.00n/a-14.8x1.2x
Thu, 09 Oct 2025AR$95.3bAR$103.8bAR$8.1b7.8x11.8x0.9x
Sat, 06 Sep 2025AR$103.2bAR$104.5bAR$9.0b8x11.4x1x
Mon, 04 Aug 2025AR$130.6bAR$102.7bAR$16.3b6.4x8x1.3x
Wed, 02 Jul 2025AR$120.8bAR$104.7bAR$17.4b6.2x7x1.2x
Fri, 30 May 2025AR$125.2bAR$104.7bAR$17.4b6.3x7.2x1.2x
Sun, 27 Apr 2025AR$113.7bAR$100.1bAR$22.4b4.6x5.1x1.1x
Tue, 25 Mar 2025AR$139.4bAR$96.9bAR$24.8b4.9x5.6x1.4x
Thu, 20 Feb 2025AR$128.6bAR$42.6bAR$18.2b6.2x7.1x3x
Sat, 18 Jan 2025AR$141.9bAR$42.6bAR$18.2b6.3x7.8x3.3x
Mon, 16 Dec 2024AR$146.2bAR$42.6bAR$18.2b6.6x8x3.4x
Wed, 13 Nov 2024AR$157.2bAR$42.6bAR$18.2b6.4x8.7x3.7x
Fri, 11 Oct 2024AR$77.5bAR$40.7bAR$4.6b12.6x17x1.9x
Sun, 08 Sep 2024AR$77.7bAR$40.7bAR$4.6b12.5x17.1x1.9x
Tue, 06 Aug 2024AR$83.1bAR$41.1b-AR$3,264,658,797.003.9x-25.4x2x
Thu, 04 Jul 2024AR$84.4bAR$41.1b-AR$3,264,658,797.004.9x-25.8x2.1x
Sat, 01 Jun 2024AR$87.3bAR$41.1b-AR$3,264,658,797.005x-26.7x2.1x
Mon, 29 Apr 2024AR$74.9bAR$43.6b-AR$10,287,966,966.006.9x-7.3x1.7x
Wed, 27 Mar 2024AR$71.7bAR$9.6b-AR$4,702,241,388.0045.7x-15.3x7.4x
Fri, 23 Feb 2024AR$79.0bAR$9.6b-AR$4,702,241,388.0059x-16.8x8.2x
Sun, 21 Jan 2024AR$70.3bAR$10.3b-AR$4,704,193,685.0037.2x-15x6.8x
Tue, 19 Dec 2023AR$61.8bAR$10.3b-AR$4,704,193,685.0034.2x-13.1x6x
Thu, 16 Nov 2023AR$51.3bAR$13.0b-AR$2,496,856,221.00n/a-20.6x3.9x
Sat, 14 Oct 2023AR$51.1bAR$13.0b-AR$2,496,856,221.00n/a-20.5x3.9x
Mon, 11 Sep 2023AR$46.9bAR$18.8b-AR$150,001,147.0017.2x-312.6x2.5x
Wed, 09 Aug 2023AR$43.2bAR$18.8b-AR$150,001,147.0013x-288.1x2.3x
Fri, 07 Jul 2023AR$41.6bAR$18.8b-AR$150,001,147.0013.5x-277.6x2.2x
Price to Earnings Ratio

-277.6x


Total Market Cap: AR$41.6bTotal Earnings: -AR$150,001,147.00Total Revenue: AR$18.8bTotal Market Cap vs Earnings and Revenue0%0%0%
Argentinian Pharma Industry Price to Earnings3Y Average -24.2x202420252026
Current Industry PE
    There is only one company in the Argentinean Pharmaceuticals industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
  • Total earnings for the Pharmaceuticals industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 85% per year.
  • This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.

Industry Comparison

How does Argentinian Pharma compare with similar industries?

AR Market-3.20%
Healthcare-3.38%
Pharma-3.38%
Pharma-3.38%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
No data available

Latest News

RICH
AR$1,570.00
Laboratorios RichmondC.I.F
7D
-3.4%
1Y
9.0%
ROSE
AR$164.00
Instituto Rosenbusch
7D
-3.0%
1Y
-7.3%